Hydroxychloroquine alone or in combination with azithromycin and corrected QT prolongation in COVID-19 patients: A systematic review

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 6

Peer-Review Report of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Meta-Analysis

ISSN

2308-3840

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Systematic Reviews

World J Meta-Anal. Dec 28, 2021; 9(6): 557-567
Published online Dec 28, 2021. doi: 10.13105/wjma.v9.i6.557

Full Size Figure Download Figure

Figure 1 The flowchart of screening the eligible studies.

Citation: Ashraf H, Ghafouri P, Kazemian S, Soleimani A, Sadat Naseri A, Karbalai S, Kazemi Saeid A. Hydroxychloroquine alone or in combination with azithromycin and corrected QT prolongation in COVID-19 patients: A systematic review. World J Meta-Anal 2021; 9(6): 557-567
URL: https://www.wjgnet.com/2308-3840/full/v9/i6/557.htm
DOI: https://dx.doi.org/10.13105/wjma.v9.i6.557

Ashraf H, Ghafouri P, Kazemian S, Soleimani A, Sadat Naseri A, Karbalai S, Kazemi Saeid A. Hydroxychloroquine alone or in combination with azithromycin and corrected QT prolongation in COVID-19 patients: A systematic review. World J Meta-Anal 2021; 9(6): 557-567 [DOI: 10.13105/wjma.v9.i6.557]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.